Alterations of mitochondrial function may play a central role in neuronal death in Huntington's disease (HD). However, the molecular mechanisms underlying such functional deficits of mitochondria are not elucidated yet. We herein showed that the expression of two important constituents of mitochondrial complex II, the 30-kDa iron-sulfur (Ip) subunit and the 70-kDa FAD (Fp) subunit, was preferentially decreased in the striatum of HD patients compared with controls. We also examined several mitochondrial proteins in striatal neurons that were infected with lentiviral vectors coding for the N-terminus part of huntingtin (Htt) with either a pathological (Htt171-82Q) or physiological (Htt171-19Q) polyglutamine tract. Compared with Htt171-19Q, expression of Htt171-82Q preferentially decreased the levels of Ip and Fp subunits and affected the dehydrogenase activity of the complex. The Htt171-82Q-induced preferential loss of complex II was not associated with a decrease in mRNA levels, suggesting the involvement of a posttranscriptional mechanism. Importantly, the overexpression of either Ip or Fp subunit restored complex II levels and blocked mitochondrial dysfunction and striatal cell death induced by Htt171-82Q in striatal neurons. The present results strongly suggest that complex II defects in HD may be instrumental in striatal cell death.
INTRODUCTIONHuntington's disease (HD) is a progressive neurodegenerative disorder caused by an abnormal expansion of a CAG repeat located in exon 1 of the gene encoding for the Huntingtin protein (Htt; The Huntington's Disease Collaborative Research Group, 1993). The mutation induces at least in part a loss of function, since wild-type Htt plays an important role in cell survival (Zuccato et al., 2003). In addition, the CAG repeat expansion leads to an abnormal polyglutamine (polyQ) tract that confers a new toxic function to full-length mutated Htt and/or short N-terminus fragments of the protein (Wellington et al., 2002;Li and Li, 2004). However, the mechanisms underlying the neuronal death induced by the polyQ expansion remain elusive.One hypothesis is that mitochondrial dysfunction is involved in striatal cell death in HD. HD patients display early striatal hypometabolism (for review, Beal, 1992), increase in lactate brain concentrations (Koroshetz et al., 1997;Jenkins et al., 1998), and reduced production of ATP in muscles (Lodi et al., 2000). Mitochondria isolated from cell expressing mutated Htt show decreased membrane potential, a defect in Ca 2ϩ homeostasis, and higher susceptibility to Ca 2ϩ -induced permeability transition (Panov et al., 2002;Choo et al., 2004).The mitochondrial hypothesis is also supported by the observation that systemic administration of the complex II inhibitor 3-nitropropionic acid (3NP) produces in rats and in nonhuman primates preferential degeneration of the striatum, abnormal movements, and frontal type cognitive deficits that are highly reminiscent of HD (for review Brouillet et al., 1999). In addition, complex II activity is severely impaired ...